Zhao Ruoxi, Zheng Shigang, Li Ying, Zhang Xueqin, Rao Dan, Chun Ze, Hu Yadong
Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu, China.
Innovation Academy for Seed Design, Chinese Academy of Sciences, Beijing, China.
J Appl Biomed. 2023 Apr;21(1):23-35. doi: 10.32725/jab.2022.019. Epub 2022 Jan 16.
Increasing data has confirmed the potential anticancer properties of Dendrobium, a traditional Chinese herb. However, most anticancer compositions from the plant of Dendrobium were usually extracted by high polar solvent, while weak polar compositions with excellent anticancer activity remained largely unexplored. In this study, the differences between ether extract and ethanol extract of Dendrobium nobile Lindl. on chemical components and anticancer activities were investigated, as well as the anticancer mechanisms among different extracts. The results demonstrated that the ether extract exhibited a stronger anticancer effect than ethanol extract, and its anticancer effect was mainly due to weak polar compounds rather than polysaccharides and alkaloids. Quantitative proteomics suggested that the ether extract significantly stimulated the over-expression of immature proteins, the endoplasmic reticulum stress and unfolded protein response were subsequently induced, the intracellular reactive oxygen species level was seriously elevated, and oxidative stress occurred in the meanwhile. Eventually, autophagy and apoptosis were activated to cause cell death. Our findings demonstrate that the ether extract of D. nobile is a potential candidate for anticancer drug development, and that future research on anticancer drugs derived from medicinal plants should also concentrate on weak polar compounds.
越来越多的数据证实了传统中草药石斛具有潜在的抗癌特性。然而,石斛属植物的大多数抗癌成分通常是用高极性溶剂提取的,而具有优异抗癌活性的弱极性成分在很大程度上仍未被探索。在本研究中,考察了金钗石斛乙醚提取物和乙醇提取物在化学成分和抗癌活性方面的差异,以及不同提取物之间的抗癌机制。结果表明,乙醚提取物比乙醇提取物表现出更强的抗癌作用,其抗癌作用主要归因于弱极性化合物,而非多糖和生物碱。定量蛋白质组学表明,乙醚提取物显著刺激未成熟蛋白质的过表达,随后诱导内质网应激和未折叠蛋白反应,细胞内活性氧水平严重升高,同时发生氧化应激。最终,自噬和凋亡被激活导致细胞死亡。我们的研究结果表明,金钗石斛乙醚提取物是抗癌药物开发的潜在候选物,并且未来对药用植物来源抗癌药物的研究也应集中在弱极性化合物上。